自体骨髓间充质干细胞治疗肝硬化的疗效及影响因素研究-effect of autologous bone marrow mesenchymal stem cells on liver cirrhosis and its influencing factors.docxVIP

自体骨髓间充质干细胞治疗肝硬化的疗效及影响因素研究-effect of autologous bone marrow mesenchymal stem cells on liver cirrhosis and its influencing factors.docx

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
自体骨髓间充质干细胞治疗肝硬化的疗效及影响因素研究-effect of autologous bone marrow mesenchymal stem cells on liver cirrhosis and its influencing factors

IV IV 摘要 关键词:骨髓间充质干细胞;移植;肝硬化;疗效;影响因素;分析 Abst Abstract V V ABSTRACT Backgroud and Objective: Liver cirrhosis (LC) is a common disease in clinical, which often dead from one or more complications, such as upper gastrointestinal hemorrhage (UGH), Spontaneous bacterial peritonitis (SBP), hepatic encephalopathy, primary hepatic carcinoma (PHC) and hepatorenal syndrome (HRS). According to the studies of 2010 global burden of disease showed that there were more than several millions people died of liver cirrhosis. Liver disease has been one of the leading causes of morbidity and mortality in the world. Recent years, bone marrow mesenchymal stem cells (BM-MSCs) transplantation has been applied to the treatment of liver diseases, but its safty and efficacy were controversy. This study is to understand the efficacy, influence factors and safety. Methods: The studies include two aspects: Meta analysis: The system searched in the Cochrane Library, Med-Line (Pub-Med) and Em-base. Journals were also hand-searched in this field. The retrieval time was from created database to February, 2014. 78 studies which used BM-MSCs in the treatment of any chronic liver disease were included. The control trail used Review Manager 5.1 software for analysis, the data before and after treatment used Meta-Analyst 3.13 software for statistical analysis. The clinical control trails study: LC patients treated with BM-MSCs transplantation plus basic treatment in our hospital during 2007 to 2012 were collected. The control group was conformed to inclusion and exclusion criteria and reasonable basic treatment, matching with propensity scores matching by years, gender and diseases category of the treatment group. The t-test was using to compare biochemical, blood coagulatin function and liver fribrosis indexes between two groups. Single factor analysis and the logistics regression analysis were used to test the influence factors of efficacy and tumorigenesis after transfusion. Using Kaplan-Meier to anal

您可能关注的文档

文档评论(0)

peili2018 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档